cbdMD, Inc.

YCBD Healthcare Drug Manufacturers Specialty & Generic

cbdMD, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $19.2 million, down 1.50% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS grew 47.6% and free cash flow grew 34.8%, each against the same quarter a year earlier.

0.35 0.01 −2.78%
Market cap
$4.0M
P/E
41.2×
Fwd P/E
−3.8×
Dividend yield
—
F-score
6/9
Altman Z
−21.65
Beneish M
−2.51
Dividend safety
n/a
Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21 Sep '22 Sep '23 Sep '24 Sep '25
Piotroski F-Score
— — 4 2 3 4 2 3 4 6
P/E ratio
0.00 0.00 0.00 0.00 3.77 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — 16.76 (0.25) 1.10 2.45 (9.35) (17.74) (23.39) (21.65)
P/S ratio
5.60 5.60 100.99 2.99 2.11 2.57 0.38 0.09 0.10 0.25
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(28.46) 1.72 17.22 (1.58) 1.11 3.57 (19.43) (41.73) (59.34) (53.04)
Beneish M-Score
— 1.13 26.13 41.82 (1.79) (3.00) (8.93) (8.40) (4.79) (2.51)
P/Operating CF
(27.89) (27.89) (63.28) (11.18) (227.79) (26.35) (6.98) (7.98) 12.11 (20.21)
P/B ratio
4.89 4.89 3.31 1.88 1.11 1.11 0.43 0.23 1.04 0.67
EV/Sales
5.60 5.60 88.58 2.81 1.79 1.98 0.19 0.06 0.10 0.26
EV/EBITDA
172.24 172.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(10.82) (10.82) (6.83) (3.99) (6.22) (6.07) (0.44) (0.29) (3.23) (2.94)
Current Ratio
0.50 2.42 12.15 4.24 3.08 5.28 3.03 1.73 0.74 2.05
Net Debt/EBITDA
(0.21) (5.69) 4.86 0.36 0.85 1.66 0.57 0.28 1.64 6.17
Debt/Equity
(2.72) 0.07 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00
ROE
(171.28%) (71.61%) (4.30%) (195.37%) 20.95% (28.47%) (110.12%) (133.22%) (140.27%) (95.30%)
ROA
(77.22%) (40.00%) (3.73%) (92.08%) 11.92% (22.02%) (89.43%) (94.55%) (57.54%) (41.67%)
ROIC
(495.92%) (3.43%) (14.91%) (28.48%) (16.70%) (16.17%) (205.28%) (194.30%) 0.00% (27.22%)
Return on Tangible Assets
437.33% (75.41%) (3.79%) (366.79%) 63.70% (80.72%) (641.47%) (654.48%) 434.13% (120.37%)
Average Days of Receivables
29.46 89.93 2,853.85 41.14 11.84 9.23 14.94 18.38 18.43 19.80
Earnings Yield
(5.53%) (5.53%) (1.55%) (66.73%) 26.53% (21.17%) (556.11%) (1,496.50%) (383.55%) (300.12%)
Free Cash Flow Yield
(9.25%) (9.25%) (12.85%) (23.51%) (13.64%) (12.69%) (116.81%) (221.06%) (30.23%) (35.06%)
Free Cash Flow per Share
(364.41) (185.54) (277.06) (335.20) (97.83) (94.66) (94.31) (18.19) (1.19) (0.41)
Book value per Share
(35.27) 408.64 652.06 758.15 646.38 676.34 189.30 35.73 3.64 1.80
Free Cash Flow
(3.02) (2.34) (5.96) (16.63) (11.98) (14.44) (15.66) (4.60) (0.64) (1.64)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates